Cellectricon, a Swedish screening technology developer, has appointed Jonas Ohlsson as its president and CEO.
Ohlsson was previously the CEO of Mentice, a developer of patient-safety products, and has held executive positions at Perkin Elmer, Applied Biosystems,and AstraZeneca.